How Amgen and AstraZeneca’s asthma drug Tezspire holds promise for colorectal cancer May 18, 2022 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on How Amgen and AstraZeneca’s asthma drug Tezspire holds promise for colorectal cancer How Amgen and AstraZeneca’s asthma drug Tezspire holds promise for colorectal cancer aliu Wed, 05/18/2022 – 11:05